Well Positioned to Redefine Immunology with Novel Oral Medicines

     Unrivaled science and expertise: Innovative, experienced team and capabilities to develop
     revolutionary oral therapies to transform the treatment of immunological diseases



     Patient-first mentality, with urgency: Rapidly advancing first-in-industry
     oral degraders with biologics-like activity


     Defining and surpassing clinical benchmarks: Demonstrated compelling
     clinical translation of degradersâ€™ impact on clinical endpoints



     Scaling for the future: Building a fully integrated global company to
     deliver a new class of immunology medicines
                                                                                                 3
